VALGANCICLOVIR MYLAN 450 MG TBL FLM 60 I

What is the maximum co-payment for VALGANCICLOVIR MYLAN?

If the insurance company contributes, the maximum co-payment is 16 160,78 Kč. The maximum pharmacy price is 33 128,26 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does VALGANCICLOVIR MYLAN have a counted co-payment set?

Yes, the medicine has a counted co-payment of 5 867,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

16 967,48 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Valganciklovir je hrazen v:
a) léčbě a sekundární profylaxi závažných CMV infekcí u HIV/AIDS pacientů,
b) profylaxi a léčbě CMV infekcí u pacientů s allogenní a autologní transplantací krvetvorných buněk,
c) profylaxi a léčbě CMV infekcí u pacientů u orgánových transplantací.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe VALGANCICLOVIR MYLAN?

infectious diseases medicine
clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
hematology and transfusion medicine, pediatric oncology and hematology
specializované pracoviště – transplantační centrum
pneumology and phthisiology, pediatric pneumology

What is the composition of VALGANCICLOVIR MYLAN?

Valganciklovir-hydrochlorid (496,3 mg), valganciklovir (450 mg), neznámá látka s kódem 3755, neznámá látka s kódem 17840, kyselina stearová, neznámá látka s kódem 10256, oxid titaničitý, neznámá látka s kódem 10258, makrogol 400, červený oxid železitý, polysorbát 80. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Documents could not be found

Which medicines are similar to VALGANCICLOVIR MYLAN?

The medicine belongs to ATC group J05AB14 – VALGANCIKLOVIR. Medicines with the same active substance can be found here.

Who manufactures VALGANCICLOVIR MYLAN?

VIATRIS LIMITED, Dublin (IRL)

Is the medicine in shortage?

The latest report from the manufacturer is from 2. 5. 2025. Production was terminated with effect from 7. 5. 2025. The manufacturer lists medicines with the following code as a potential substitute: